Mathias Warm

Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial

Michael Untch, Christian Jackisch, Andreas Schneeweiß et al. · The Lancet Oncology · 2016 · 414 citations

Medicine, Oncology, Pharmacology +10

Determinants and patient-reported long-term outcomes of physician empathy in oncology: A structural equation modelling approach

Melanie Neumann, Markus Wirtz, Elfriede Bollschweiler et al. · Patient Education and Counseling · 2007 · 254 citations

Social Sciences, Medical Education, Oncology +11

Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results

Oleg Gluz, Ulrike Nitz, Cornelia Liedtke et al. · JNCI Journal of the National Cancer Institute · 2017 · 132 citations · Full text

Medicine, Oncology, Pharmacology +17

Real-Time Sonoelastography Performed in Addition to B-Mode Ultrasound and Mammography: Improved Differentiation of Breast Lesions?

Anke Thomas, Sherko Kümmel, Florian Fritzsche et al. · Academic Radiology · 2006 · 128 citations

Medicine, Radiology, Diagnostic Imaging +12

Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial

Sibylle Loibl, Christian Jackisch, Sabine Schmatloch et al. · Annals of Oncology · 2016 · 117 citations

Medicine, Oncology, Pharmacology +15